AR-13154

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameAR-13154

Drug Alias NameAR-13154

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPlatelet-derived growth factor receptor beta inhibitorsTyrosine-protein kinase JAK1 inhibitorsRho-associated protein kinase 1 inhibitors

TargetsPlatelet-derived growth factor receptor betaRho-associated protein kinase 1Tyrosine-protein kinase JAK1

Therapy Area/IndicationsMacular Degeneration

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAerie Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAerie Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsMacular Degeneration

Other Information

ATC CodeN/A